⚡️ Solace Set to Be Valued at Over $300M in New Series B Round

Patient advocate startup Solace is raising a Series B funding round led by Menlo Ventures, valuing the company at more than $300 million. The new funding aims to expand its platform connecting patients with healthcare advocates.

What’s inside the deal:

✅ Series B funding round led by Menlo Ventures
✅ Valuation expected to exceed $300 million
✅ Target raise: $40 million
✅ Previous funding: $21 million, including $14 million Series A from Inspired Capital, Craft Ventures, Torch Capital, and angel investors Anne Wojcicki and Susan Wojcicki

Why it matters:

💡 Solace connects Medicare patients with healthcare advocates to handle tasks like scheduling and insurance appeals, filling a critical gap in patient care.
💡 The company operates in all 50 states, offering support for over 100 conditions through virtual consultations with former healthcare professionals.
💡 Medicare recently began covering patient advocacy services, boosting the startup’s potential for growth.
💡 The company’s revenue run rate reached $10 million at the start of 2025.

With more startups addressing the complexities of healthcare, Solace's innovative patient-centric approach positions it as a key player in transforming healthcare navigation.

✔️Powered by V3V Ventures